Company Search:
Advanced Search
Sponsored Links
Eyegate Pharmaceuticals Inc Company Snapshot
Eyegate Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eyegate Pharmaceuticals Inc with three other companies in this sector in the United States: Otonomy Inc (2016 sales of $683,000.00 of which 100% was Biopharmaceuticals), Ovascience Inc ($653,000.00 of which 100% was Diagnostic Substance), and Corix Bioscience Inc ($693,621.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eyegate Pharmaceuticals Inc
  Stock Performance Chart for Eyegate Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.26
(Figures in U.S. Dollars)
1 Week 12.6%   13 Weeks -0.7%  
4 Weeks 12.6%   52 Weeks -19.2%  
Eyegate Pharmaceuticals Inc Key Data:
  Ticker: EYEG Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 669,259
(Year Ending Jan 2017).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 21,695,225
  Fiscal Yr Ends: December Shares Outstanding: 17,204,778
  Share Type: Common Closely Held Shares: 716,431
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.